The landscape for 'Other Medical Consumables & Accessories' is undergoing a fundamental shift, driven by the global rise in chronic diseases, particularly diabetes. With over 537 million adults living with diabetes worldwide—a figure expected to surge to 783 million by 2045—the demand for reliable, at-home monitoring solutions has never been higher [1]. This trend has catapulted the blood glucose monitoring market into a central position within the broader medical consumables sector. Grand View Research projects the global blood glucose monitoring market to grow at a CAGR of 8.5% from 2024 to 2030, underpinned by this relentless increase in patient numbers and a growing emphasis on self-care [1].
For Southeast Asian (ASEAN) manufacturers, this presents a golden, yet complex, opportunity. Alibaba.com internal data shows that the 'Other Medical Consumables' category is experiencing robust trade growth, with key destination markets in North America and Europe exhibiting strong buyer activity. However, the path to capturing value is no longer a simple race to the bottom on price. The market is bifurcating: on one end, a commoditized segment focused on the lowest possible cost, and on the other, a premium segment where quality, regulatory compliance, and brand trust are the primary currencies.
Market Size and Growth Projections
| Market Segment | 2023 Value | Projected 2030 Value | CAGR (2024-2030) | Primary Growth Driver |
|---|---|---|---|---|
| Global Medical Consumables | $150.2 Billion | $189.7 Billion | 3.4% | Aging population, hospital demand |
| Blood Glucose Monitoring | $24.5 Billion | $42.1 Billion | 8.5% | Rising global diabetes prevalence |
| Test Strips (Sub-segment) | $18.0 Billion+ | $30.0 Billion+ | ~9.0% | Shift to home-based patient management |

